The Latest Cardiac and Vascular News
BAUDETTE, Minn., June 30, 2020 /PRNewswire/ — ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. market for this product is approximately $16 million, according to IQVIA/IMS Health. Patrick Walsh, ANI’s Interim President and CEO, stated, “This is our sixth generic […]
BAUDETTE, Minn., Oct. 31, 2019 /PRNewswire/ — ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq: ANIP) today announced that its partner Pharmaceutics International Inc. (Pii) has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml). ANI plans to launch this currently unavailable drug in December, introducing this critical drug for the treatment of ventricular fibrillation and life-threatening […]
